BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26722059)

  • 1. Clinical Features and Treatment Outcomes in Patients with Extragonadal Germ Cell Tumors: A Single-center Experience.
    Makino T; Konaka H; Namiki M
    Anticancer Res; 2016 Jan; 36(1):313-7. PubMed ID: 26722059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to classify, diagnose, treat and follow-up extragonadal germ cell tumors? A systematic review of available evidence.
    Winter C; Zengerling F; Busch J; Heinzelbecker J; Pfister D; Ruf C; Lackner J; Albers P; Kliesch S; Schmidt S; Bokemeyer C
    World J Urol; 2022 Dec; 40(12):2863-2878. PubMed ID: 35554637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extragonadal germ cell tumors in Taiwan: an analysis of treatment results of 59 patients.
    Hsu YJ; Pai L; Chen YC; Ho CL; Kao WY; Chao TY
    Cancer; 2002 Aug; 95(4):766-74. PubMed ID: 12209720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose chemotherapy with autologous stem cell support in patients with metastatic non-seminomatous testicular cancer - a report from the Swedish Norwegian Testicular Cancer Group (SWENOTECA).
    Haugnes HS; Laurell A; Stierner U; Bremnes RM; Dahl O; Cavallin-Ståhl E; Cohn-Cedermark G
    Acta Oncol; 2012 Feb; 51(2):168-76. PubMed ID: 22175254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic variables for response and outcome in patients with extragonadal germ-cell tumors.
    Hartmann JT; Nichols CR; Droz JP; Horwich A; Gerl A; Fossa SD; Beyer J; Pont J; Kanz L; Einhorn L; Bokemeyer C
    Ann Oncol; 2002 Jul; 13(7):1017-28. PubMed ID: 12176779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extragonadal germ cell tumors of the mediastinum and retroperitoneum: results from an international analysis.
    Bokemeyer C; Nichols CR; Droz JP; Schmoll HJ; Horwich A; Gerl A; Fossa SD; Beyer J; Pont J; Kanz L; Einhorn L; Hartmann JT
    J Clin Oncol; 2002 Apr; 20(7):1864-73. PubMed ID: 11919246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a subgroup with worse prognosis among patients with poor-risk testicular germ cell tumor.
    Kojima T; Kawai K; Tsuchiya K; Abe T; Shinohara N; Tanaka T; Masumori N; Yamada S; Arai Y; Narita S; Tsuchiya N; Habuchi T; Nishiyama H
    Int J Urol; 2015 Oct; 22(10):923-7. PubMed ID: 26094715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Male Extragonadal Germ Cell Tumors of the Adult.
    Busch J; Seidel C; Zengerling F
    Oncol Res Treat; 2016; 39(3):140-4. PubMed ID: 27032104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors in germ cell tumour patients with relapse or progressive disease after first-line chemotherapy: evaluation of a prognostic score for survival after high-dose chemotherapy.
    Sammler C; Beyer J; Bokemeyer C; Hartmann JT; Rick O
    Eur J Cancer; 2008 Jan; 44(2):237-43. PubMed ID: 18055194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extragonadal germ cell tumors: relation to testicular neoplasia and management options.
    Bokemeyer C; Hartmann JT; Fossa SD; Droz JP; Schmol HJ; Horwich A; Gerl A; Beyer J; Pont J; Kanz L; Nichols CR; Einhorn L
    APMIS; 2003 Jan; 111(1):49-59; discussion 59-63. PubMed ID: 12752235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long term results of treatment in patients with extragonadal germ cell tumours.
    Gutierrez Delgado F; Tjulandin SA; Garin AM
    Eur J Cancer; 1993; 29A(7):1002-5. PubMed ID: 7684595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extragonadal germ cell tumors in Japan.
    Ebi H; Nakata M; Tahara M; Igarashi T; Kawada K; Itoh K; Ueda R; Minami H
    Cancer Sci; 2003 Dec; 94(12):1107-11. PubMed ID: 14662028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.
    Fizazi K; Prow DM; Do KA; Wang X; Finn L; Kim J; Daliani D; Papandreou CN; Tu SM; Millikan RE; Pagliaro LC; Logothetis CJ; Amato RJ
    Br J Cancer; 2002 May; 86(10):1555-60. PubMed ID: 12085204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platinum-based chemotherapy of primary extragonadal germ cell tumours: the Hellenic Cooperative Oncology Group experience.
    Pectasides D; Aravantinos G; Visvikis A; Bakoyiannis C; Halikia A; Kalofonos C; Kosmidis P; Skarlos D; Fountzilas G
    Oncology; 1999 Jul; 57(1):1-9. PubMed ID: 10394118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extragonadal germ cell tumors: clinical presentation and management.
    Albany C; Einhorn LH
    Curr Opin Oncol; 2013 May; 25(3):261-5. PubMed ID: 23422328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of outcome in patients with advanced nonseminomatous germ cell testicular tumors.
    Yetisyigit T; Babacan N; Urun Y; Seber ES; Cihan S; Arpaci E; Yildirim N; Aksoy S; Budakoglu B; Zengin N; Oksuzoglu B; Yalcin BC; Alkis N
    Asian Pac J Cancer Prev; 2014; 15(2):831-5. PubMed ID: 24568504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors.
    Hartmann JT; Fossa SD; Nichols CR; Droz JP; Horwich A; Gerl A; Beyer J; Pont J; Fizazi K; Hecker H; Kanz L; Einhorn L; Bokemeyer C
    J Natl Cancer Inst; 2001 Nov; 93(22):1733-8. PubMed ID: 11717334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage chemotherapy in patients with extragonadal nonseminomatous germ cell tumors: the Indiana University experience.
    Saxman SB; Nichols CR; Einhorn LH
    J Clin Oncol; 1994 Jul; 12(7):1390-3. PubMed ID: 8021729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study.
    Wessalowski R; Schneider DT; Mils O; Friemann V; Kyrillopoulou O; Schaper J; Matuschek C; Rothe K; Leuschner I; Willers R; Schönberger S; Göbel U; Calaminus G;
    Lancet Oncol; 2013 Aug; 14(9):843-52. PubMed ID: 23823158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: the EBMT experience.
    De Giorgi U; Demirer T; Wandt H; Taverna C; Siegert W; Bornhauser M; Kozak T; Papiani G; Ballardini M; Rosti G;
    Ann Oncol; 2005 Jan; 16(1):146-51. PubMed ID: 15598952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.